Reducing and managing chronic obstructive pulmonary disease exacerbations with tiotropium + olodaterol.
Gerard J CrinerSean DuffyPublished in: Current medical research and opinion (2020)
The early stages of COPD may represent a "window of therapeutic opportunity" during which initiation of tiotropium and olodaterol dual bronchodilator therapy may improve lung function and quality of life and reduce exacerbations in patients with COPD.